CTRI/2016/09/007263已完成未知
A Randomized Prospective Investigator Blinded study of Bowel Preparation for Colonoscopy with Magnesium Sulphate versus Polyethylene Glycol at a single centre.
Dr Naresh Bhat0 个研究点目标入组 120 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All patients who are required to undergo colonoscopy
排除标准
- •Multiple comorbidities-CVA/ACS
- •Renal failure on Dialysis
- •Bowel obstruction
- •Sick patient in ICU
- •Major suergy for colon
- •Age more than 70 yrs
研究者
相似试验
已完成
不适用
A randomised, investigator and subject blinded, placebo-controlled study to determine the safety, tolerability, and pharmacokinetics of INF904 in healthy subjects after single and multiple ascending dosesNL-OMON53655InflaRx GmbH86
进行中(未招募)
1 期
Clinical Study to Assess the Mode of Action of QBW251 in Patients With Chronic Obstructive Pulmonary Disease (COPD)EUCTR2019-000325-49-DEovartis Pharma AG100
进行中(未招募)
1 期
Clinical Study to Assess the Mode of Action of QBW251 in Patients With Chronic Obstructive Pulmonary Disease (COPD)EUCTR2019-000325-49-GBovartis Pharma AG100
进行中(未招募)
1 期
A study to assess different investigational drugs for the treatment of hidradenitis suppurativaMedDRA version: 20.0Level: LLTClassification code 10020041Term: Hidradenitis suppurativaSystem Organ Class: 100000004858Hidradenitis suppurativaEUCTR2018-002757-30-BEovartis Pharma AG200
进行中(未招募)
1 期
A study to assess different investigational drugs for the treatment of hidradenitis suppurativaHidradenitis suppurativaEUCTR2018-002757-30-FRovartis Pharma AG90
